Skip to content

MiMedx Group MDXG Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
Vericel logo
VericelVCEL
Axogen logo
AxogenAXGN
Establishment Labs logo
Establishment LabsESTA
ICU Medical logo
ICU MedicalICUI
Alphatec Holdings logo
Alphatec HoldingsATEC

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's operating lease right-of-use asset amortization?
MiMedx Group (MDXG) reported operating lease right-of-use asset amortization of $330K in Q1 2026.
How has MiMedx Group's operating lease right-of-use asset amortization changed year-over-year?
MiMedx Group's operating lease right-of-use asset amortization increased by 7.5% year-over-year, from $307K to $330K.
What is the long-term trend for MiMedx Group's operating lease right-of-use asset amortization?
Over 4 years (2021 to 2025), MiMedx Group's operating lease right-of-use asset amortization has grown at a 6.3% compound annual growth rate (CAGR), from $989K to $1.26M.